Sherry Aulin, Chief Financial Officer at Xenon Pharmaceuticals Inc. (XENE), sold 44,043 shares at $41.19 ($1.8M) on 2024-12-18, disclosed to the SEC on 2024-12-19.
Open-market sale of $1.8M XENE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.19 | 11,510 | $474K | 26.1% |
| 2 | $41.19 | 11,510 | $474K | 26.1% |
| 3 | $41.23 | 7,199 | $297K | 16.4% |
| 4 | $41.23 | 7,199 | $297K | 16.4% |
| 5 | $41.28 | 2,135 | $88K | 4.9% |
| 6 | $41.28 | 4,490 |
| $185K |
| 10.2% |
| Total | $41.22 avg | 44,043 | $1.8M | 100% |